Journal article
Long-Term Follow-Up of Outcomes With F-18-Fluorodeoxyglucose Positron Emission Tomography Imaging–Assisted Management of Patients With Severe Left Ventricular Dysfunction Secondary to Coronary Disease
Abstract
BACKGROUND: Whether viability imaging can impact long-term patient outcomes is uncertain. The PARR-2 study (Positron Emission Tomography and Recovery Following Revascularization) showed a nonsignificant trend toward improved outcomes at 1 year using an F-18-fluorodeoxyglucose positron emission tomography (PET)-assisted strategy in patients with suspected ischemic cardiomyopathy. When patients adhered to F-18-fluorodeoxyglucose PET …
Authors
Mc Ardle B; Shukla T; Nichol G; deKemp RA; Bernick J; Guo A; Lim SP; Davies RA; Haddad H; Duchesne L
Journal
Circulation Cardiovascular Imaging, Vol. 9, No. 9,
Publisher
Wolters Kluwer
Publication Date
September 2016
DOI
10.1161/circimaging.115.004331
ISSN
1941-9651
Associated Experts
Fields of Research (FoR)
Sustainable Development Goals (SDG)
Medical Subject Headings (MeSH)
AgedCanadaCoronary Artery DiseaseDisease-Free SurvivalFemaleFluorodeoxyglucose F18HumansMaleMiddle AgedMyocardial InfarctionMyocardial RevascularizationMyocardiumPatient ReadmissionPositron Emission Tomography Computed TomographyPredictive Value of TestsRadiopharmaceuticalsRisk FactorsSeverity of Illness IndexTime FactorsTissue SurvivalTreatment OutcomeVentricular Dysfunction, LeftVentricular Function, Left